Professional Documents
Culture Documents
BR Emdex 1609
BR Emdex 1609
BR Emdex 1609
EMDEX
Dextrates, NF
Multifunctional Excipient
Soluble DC Binder and Filler in One
Excellent Flow and Compaction
Superb Taste and Tablet Appearance
EMDEX ®
Dextrates, NF
Introduction Benefits
EMDEX ® is a directly compressible, water-soluble tablet • Superior flow, compaction, and tablet robustness in
binder and filler. Its unique composition of 95 % glucose direct compression applications
monohydrate and different oligosaccharides derived • Does not require a glidant, due to superior flow
from starch is monographed under “dextrates” in the NF. properties
With use levels ranging from 1 % to 99 %, EMDEX ® is • Exhibits excellent mixing properties
designed for a variety of tablet applications. • Easy to handle – does not stick to punches
• Non-dusting
• Results in smooth, shiny tablets
• Tablets demonstrate very low friability
Physical Properties • Ideally suited for lactose-intolerant patients
• Enables lactose-free line extensions
• Freely and rapidly water soluble (1000 g/L) • Metabolizes fully without osmotic laxative effect
• Natural sweet taste of dextrose • Provides patients with a pleasant, sweet taste and a
• Spherical, porous particles cool mouth feel
• Excellent flowability • Does not cause dry mouth feel when compared to
• High bulk density sugar alcohols
• Calorie content: 4.0 - 4.5 kcal/gram • Particle porosity improves EMDEX ®’s solubility and
• Narrow particle size distribution flavor absorption capacity – a key advantage for tablet
taste enhancement
• Compendial (NF), eliminating regulatory hurdles
Powder Properties
Bulk Density 0.70 g/m³
Tapped Density 0.75 g/m³
Hausner Ratio 1.07
Angle of Repose 30°
Loss on Drying 7.8 - 9.2 (glucose monohydrate,
the assay includes crystal water)
Dextrose Equivalent 93 - 99 % 300 µm
Heat of Solution -105 J/g ®
Micrograph of EMDEX Tablet Surface
Medium Particle Size 190 - 220 µm
Tab. 1: Powder Properties of EMDEX®
300 µm
2
Applications Functional Aspects
EMDEX ® is designed for a variety of tablet types including: Particle Size and Morphology
• Chewable tablets
• Ingestible tablets 10
9
• Dispersible tablets
8
• Effervescent tablets
7
• Soluble tablets
Special Applications 0
0,4
0,8
1,0
2,0
3,5
4,2
5,1
6,2
7,4
8,9
10,8
22,7
33,0
47,9
57,8
69,6
83,9
101,1
121,8
146,8
176,9
213,2
256,9
309,6
373,1
449,7
541,9
653,0
786,9
948,3
1.143,0
1.377,0
1.660,0
2.000,0
• Because EMDEX ® is 100 % water soluble, it is also Particle Size [µm]
perfect for applications in which a good mouth feel or Fig. 1: Particle Size Distribution of EMDEX® (Dextrates)
a clear solution are required
• EMDEX ®’s excellent flowability and non-dustiness
makes it appropriate to be used as a flow • EMDEX ® exhibits a narrow particle size distribution
improvement aid in sachets and stickpacks with an average particle size of 200 µm. Along with
• EMDEX ® is a porous material that absorbs fluids, its spherical particle shape and high bulk density,
allowing chewable formulation development and this ensures supreme flow properties
manufacture using liquid APIs • The porous structure of the spray-dried EMDEX ®
• Highly suited for chewable animal health products, particles enables excellent content uniformity even for
especially for dogs, who are particularly fond of its low-dose, micronized APIs
pleasant taste • Oily APIs are readily absorbed by the sponge-like
• EMDEX ® should not be used for APIs, which are structure of EMDEX ®
incompatible with reducing sugars
300 µm 300 µm
3
EMDEX ®Dextrates, NF
Compactibility Flowability
50
2,40 EMDEX® (Dextrates) ®
EMDEX
2,20 Glucose
Spray-dried lactose
2,00 40
Spray-dried lactose
Anhydrous lactose
Tensile Strength [MPa]
1,60
30
1,40
1,20
20
1,00
0,80
0,60 10
a 30°
0,40
0,20
0
0,00
A n g l e o f Re p o s e
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 20 Fig. 3: Formulation Mixture:
Compression Force [kN] 1 % PRUV ® (Sodium Stearyl Fumarate), 99 % EMDEX ®
Lactose is the most widely used water-soluble filler-binder. Due to its high bulk density and spherical particle shape,
EMDEX ® is significantly more compactible than spray- EMDEX ® exhibits excellent flowability. This functional
dried lactose, while exhibiting the same (brittle) binding advantage can be utilized in pure form or for flow
mechanism. enhancement in tableting blends and stickpacks.
30
tablet strength. 200
25
150
20
15 100
10
50
5
0 0
0 10 20 30 40 50 60 70 80 90 100 % EMDEX®
100 90 80 70 60 50 40 30 20 10 0 % MCC
4
Case Study: Comparison of Different Water-Soluble Direct Compression Binders
with Vitamin C Powder
Formulation
Results
As shown in Table 4, the target tablet hardness of DC-grade sorbitol and Isomalt resulted in tablets of the
70 N was not reached with the formulations based on desired hardness at reasonably low compaction forces.
mannitol and glucose monohydrate respectively. Their friability values, however, were too high.
Granulated lactose required excessive compaction forces Only the EMDEX ® formulation produced tablets of satis-
to reach the target hardness yet yielded tablets of factory hardness and friability, while also showing
unacceptable friability. outstanding disintegration properties.
5
EMDEX ®
Dextrates, NF
Model Formulations
Vitamin C Antacid
mg/tablet mg/tablet
Ascorbic Acid, Granulated 45.0 Aluminium Hydroxide 400.0
Sodium Ascorbate 83.0 Silic Acid 50.0
Orange Flavor 8.5 Flavor 20.0
PRUV ® Sodium Stearyl Fumarate 6.4 PRUV ® Sodium Stearyl Fumarate 16.0
®
EMDEX Dextrates 607.1 EMDEX® Dextrates 1014.0
Total Weight 750.0 Total Weight 1500.0
Tab. 5 Tab. 11
Multivitamin Simethicone
mg/tablet mg/tablet
Multivitamin Mixture 40.0 - 64.0 Simethicone Mix 42.0
®
®
EMDEX Dextrates 648.0 - 672.0 PRUV Sodium Stearyl Fumarate 10.0
Gummi Arabicum 75.0 EMDEX® Dextrates 440.0
Xylitol 5.0 Total Weight 492.0
Tab. 13
Flavor (Orange & Lemon) 4.0
PRUV ® Sodium Stearyl Fumarate 4.0 Tablet Diameter 13 mm
Total Weight 800.0 Compression Force 15 - 17 kN
Tab. 7 Crushing Strength 70 - 80 N
Tab. 14
Compression Force 7-8
7 -kN
8 kN
Hardness
Crushing Strength 90
9-11
- 110
kp N
Tab. 8
Effervescent Tablets:
Acetylsalicylic Acid
mg/tablet
Acetylsalicylic Acid 500.0
Natrium Hydrogen Carbonate 400.0
Citric Acid 350.0
PRUV ® Sodium Stearyl Fumarate 20.0
®
EMDEX Dextrates 800.0
Total Weight 2070.0
Tab. 9
Tablet Diameter 16 mm
Compression Force 15 kN
Crushing Strength 140 N
Tab. 10
6
Regulatory Information
• Conforms to NF
• GMO-free grade available
• GMO-free grades fall under food regulations for
Sample Sizes
400 g and 2 kg containers available.
Case Studies
Case studies and formulation examples are available
upon request. Please contact your sales rep for more
information or visit www.jrspharma.com.
Disclaimer:
The information provided in this brochure is based on thorough research and
is believed to be completely reliable. Application suggestions are given to assist
our customers, but are for guidance only. Circumstances in which our material
is used vary and are beyond our control. Therefore, we cannot
assume any responsibility for risks or liabilities, which may result
from the use of this technical advice.
7
Pharmaceutical Contract Pharma
www.project-pharmaceutics.com www.celonic.com
Customers’ Needs
Convenience
Outsourcing
Total Cost Savings
Animal Health
Global Services
41002_GB_V4_2.01609KE
Nutraceuticals
Innovation
System
Solution
Supplier
www.jrspharma.com